Engineers Gate Manager’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Buy |
116,101
+98,903
| +575% | +$1.38M | 0.02% | 848 |
|
|
2025
Q1 | $234K | Sell |
17,198
-36,160
| -68% | -$492K | ﹤0.01% | 1826 |
|
|
2024
Q4 | $1.09M | Buy |
+53,358
| New | +$1.09M | 0.02% | 958 |
|
|
2024
Q3 | – | Sell |
-11,130
| Closed | -$258K | – | 2183 |
|
|
2024
Q2 | $258K | Sell |
11,130
-20,226
| -65% | -$470K | 0.01% | 1541 |
|
|
2024
Q1 | $643K | Buy |
31,356
+18,684
| +147% | +$383K | 0.02% | 1062 |
|
|
2023
Q4 | $272K | Sell |
12,672
-10,937
| -46% | -$235K | 0.01% | 1507 |
|
|
2023
Q3 | $487K | Sell |
23,609
-8,211
| -26% | -$169K | 0.02% | 1077 |
|
|
2023
Q2 | $939K | Sell |
31,820
-24,965
| -44% | -$737K | 0.04% | 729 |
|
|
2023
Q1 | $1.31M | Buy |
+56,785
| New | +$1.31M | 0.05% | 477 |
|
|
2022
Q3 | – | Sell |
-17,320
| Closed | -$510K | – | 1721 |
|
|
2022
Q2 | $510K | Buy |
17,320
+1,274
| +8% | +$37.5K | 0.02% | 1101 |
|
|
2022
Q1 | $516K | Buy |
16,046
+10,356
| +182% | +$333K | 0.02% | 1049 |
|
|
2021
Q4 | $254K | Buy |
+5,690
| New | +$254K | 0.01% | 1507 |
|
|
2021
Q3 | – | Sell |
-6,030
| Closed | -$473K | – | 1718 |
|
|
2021
Q2 | $473K | Sell |
6,030
-8,550
| -59% | -$671K | 0.03% | 860 |
|
|
2021
Q1 | $833K | Buy |
14,580
+9,400
| +181% | +$537K | 0.04% | 670 |
|
|
2020
Q4 | $434K | Sell |
5,180
-2,876
| -36% | -$241K | 0.02% | 1060 |
|
|
2020
Q3 | $289K | Buy |
+8,056
| New | +$289K | 0.01% | 1269 |
|
|
2020
Q1 | – | Sell |
-12,793
| Closed | -$223K | – | 1650 |
|
|
2019
Q4 | $223K | Buy |
+12,793
| New | +$223K | 0.01% | 1419 |
|